Federal

Expressing support for designation of March 3, 2023, as "National Triple-Negative Breast Cancer Day".

Source: Congress.gov · 299 words in original text

What This Bill Does

This resolution expresses the House of Representatives' support for naming March 3, 2023, as "National Triple-Negative Breast Cancer Day." The resolution aims to create awareness about triple-negative breast cancer and its impact on families in the United States.

Who It Affects

The resolution directly addresses triple-negative breast cancer, which the bill states disproportionately affects young women, Black and Hispanic women, and those with BRCA gene mutations (a genetic change that increases cancer risk).

Key Provisions

The bill contains only one actionable provision: • The House of Representatives supports designating March 3, 2023, as "National Triple-Negative Breast Cancer Day" to raise awareness of these cancers' devastating effects on families and to emphasize the need for strong action to eliminate triple-negative breast cancer (Resolved paragraph, lines 1-6)

What Changes

Not specified in bill text. This is a resolution expressing support rather than a law that creates specific changes or requirements.

Important Definitions

Triple-negative breast cancer is a type of breast cancer that is estrogen receptor-negative (does not respond to estrogen), progesterone receptor-negative (does not respond to progesterone), and HER2-negative (a specific protein is not present).

IV 118TH CONGRESS 1ST SESSION H. RES. 172 Expressing support for designation of March 3, 2023, as ‘‘National Triple- Negative Breast Cancer Day’’. IN THE HOUSE OF REPRESENTATIVES FEBRUARY 27, 2023 Mr. MORELLE submitted the following resolution; which was referred to the Committee on Oversight and Accountability RESOLUTION Expressing support for designation of March 3, 2023, as ‘‘National Triple-Negative Breast Cancer Day’’. Whereas triple-negative breast cancer was recognized as a distinct type of cancer in 2006; Whereas triple-negative breast cancer disproportionately af- fects young women, Black and Hispanic women, and those with BRCA gene mutations; Whereas triple-negative breast cancers are estrogen receptor- negative, progesterone receptor-negative, and HER2-neg- ative, making them distinct from other breast cancers; Whereas there is no targeted therapy for triple-negative breast cancers; Whereas 10 to 20 percent of all breast cancer diagnoses are designated as triple-negative; VerDate Sep 11 2014 01:40 Feb 28, 2023 Jkt 039200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\HR172.IH HR172 kjohnson on DSK79L0C42PROD with BILLS 2 •HRES 172 IH Whereas triple-negative breast cancer can be more aggressive and more likely to spread and recur; Whereas triple-negative breast cancer accounts for around 25 percent of all deaths from breast cancer in the United States; and Whereas March 3, 2023, would be an appropriate date to designate as ‘‘National Triple-Negative Breast Cancer Day’’: Now, therefore, be it Resolved, That the House of Representatives supports 1 the designation of ‘‘National Triple-Negative Breast Can- 2 cer Day’’ to create awareness of the devastating effect of 3 these cancers on families in the United States and the 4 need for strong action to eradicate triple-negative breast 5 cancer. 6 Æ VerDate Sep 11 2014 01:40 Feb 28, 2023 Jkt 039200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6301 E:\BILLS\HR172.IH HR172 kjohnson on DSK79L0C42PROD with BILLS

Important: This plain English summary was generated by AI and is provided for informational purposes only. It is not legal advice. Always consult the official bill text on Congress.gov or a qualified attorney for legal matters.